The experimental endpoint in the PBS and Luc controls was reached around the tenth day of treatment, while IFNβ alone or in combination with p14ARF show significantly reduced tumor growth (Figure 2A) and prolonged survival (Figure 2B). This evidence concerns the gene IFNB1 and neoplasm.